Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
AIDS (London, England)
|
June 24, 2003
Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen
Michael A Polis, Daniel L Suzman, Christian P Yoder, et al.
JCO Precision Oncology
|
August 29, 2024
False-Positive Circulating Tumor DNA Results Do Not Explain Lack of Efficacy for PARP Inhibitors in Patients With Castration-Resistant Prostate Cancer Harboring <i>ATM</i> and <i>CHEK2</i> Mutations
Jaleh Fallah, Jianjin Xu, Hee-Koung Joeng, et al.
JNCI Cancer Spectrum
|
July 16, 2025
The Food and Drug Administration pooled analysis of overall survival according to depth of response in frontline advanced immune-oncology renal cell carcinoma trials
Elaine Chang, Haley Gittleman, Chi Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2024
A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma
Elaine Chang, Jiaxi Zhou, Chi Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2022
FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer
Jaleh Fallah, Sundeep Agrawal, Haley Gittleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2020
Regulatory Considerations for Contribution of Effect of Drugs Used in Combination Regimens: Renal Cell Cancer Case Studies
Jamie R Brewer, Elaine Chang, Sundeep Agrawal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 4, 2024
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma
Michael H Brave, William F Maguire, Chana Weinstock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2024
US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer
Brian L Heiss, Elaine Chang, Xin Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2021
U.S. FDA Drug Approvals for Gynecological Malignancies: A Decade in Review
Shaily Arora, Preeti Narayan, Gwynn Ison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 18, 2025
FDA Approval Summary: Nogapendekin Alfa Inbakicept-pmln with BCG for BCG-unresponsive carcinoma in situ
Brian L Heiss, Elaine Chang, Hee-Koung Joeng, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
AIDS (London, England)
|
June 24, 2003
Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen
Michael A Polis, Daniel L Suzman, Christian P Yoder, et al.
JCO Precision Oncology
|
August 29, 2024
False-Positive Circulating Tumor DNA Results Do Not Explain Lack of Efficacy for PARP Inhibitors in Patients With Castration-Resistant Prostate Cancer Harboring <i>ATM</i> and <i>CHEK2</i> Mutations
Jaleh Fallah, Jianjin Xu, Hee-Koung Joeng, et al.
JNCI Cancer Spectrum
|
July 16, 2025
The Food and Drug Administration pooled analysis of overall survival according to depth of response in frontline advanced immune-oncology renal cell carcinoma trials
Elaine Chang, Haley Gittleman, Chi Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2024
A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma
Elaine Chang, Jiaxi Zhou, Chi Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2022
FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer
Jaleh Fallah, Sundeep Agrawal, Haley Gittleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2020
Regulatory Considerations for Contribution of Effect of Drugs Used in Combination Regimens: Renal Cell Cancer Case Studies
Jamie R Brewer, Elaine Chang, Sundeep Agrawal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 4, 2024
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma
Michael H Brave, William F Maguire, Chana Weinstock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2024
US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer
Brian L Heiss, Elaine Chang, Xin Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2021
U.S. FDA Drug Approvals for Gynecological Malignancies: A Decade in Review
Shaily Arora, Preeti Narayan, Gwynn Ison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 18, 2025
FDA Approval Summary: Nogapendekin Alfa Inbakicept-pmln with BCG for BCG-unresponsive carcinoma in situ
Brian L Heiss, Elaine Chang, Hee-Koung Joeng, et al.
Page
of 5